Catalyst Wire Dossier Catalyst Wire Dossier

PepGNP-ChikV

· Gylden Pharma Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PepGNP-ChikV, covering 2026-02-06 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of PepGNP-ChikV in Healthy Volunteers [EARLY_Phase 1]

See pricing